Lv11
20 积分 2024-04-09 加入
Oral agents for lowering lipoprotein(a)
16分钟前
待确认
Muvalaplin: A Novel Oral Therapy for Targeted Reduction of Plasma Lipoprotein(a)
1小时前
已完结
EGFR Mutations and Lung Cancer
2个月前
已完结
Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis
2个月前
已完结
Androgenetic alopecia
3个月前
已完结
Oral GLP-1 Receptor Agonists for Weight Loss
5个月前
已完结
GLP-1 receptor agonists
5个月前
已完结
AZD0780, the first oral small molecule PCSK9 inhibitor for the treatment of hypercholesterolemia: Results from a randomized, single-blind, placebo-controlled phase 1 trial
6个月前
已完结
Cryo-EM structures of GPR75 reveal an occluded orthosteric pocket challenging conventional drug discovery paradigms for an anti-obesity target
8个月前
已完结
GIP-derived GIP receptor antagonists – a review of their role in GIP receptor pharmacology
11个月前
已完结
皖公网安备34019202002308
